Login to Your Account



Financings Roundup

Neurocrine Pads Coffers with $77M Public Offering for R&D

By Catherine Shaffer
BioWorld Today Contributing Writer

Friday, January 20, 2012
Neurocrine Biosciences Inc., of San Diego, priced an underwritten public offering 9.5 million shares of common stock at $8. 10 per share, a 6.25 percent discount to Wednesday's closing price, for gross proceeds of $77 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription